BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 8870673)

  • 1. Predicted alpha-helix/beta-sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7.
    Ullman CG; Haris PI; Galloway DA; Emery VC; Perkins SJ
    Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):229-39. PubMed ID: 8870673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing the spacing between metal-binding motifs decreases stability and transforming activity of the human papillomavirus type 18 E7 oncoprotein.
    Watanabe S; Sato H; Furuno A; Yoshiike K
    Virology; 1992 Oct; 190(2):872-5. PubMed ID: 1325712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A C-terminal hydrophobic, solvent-protected core and a flexible N-terminus are potentially required for human papillomavirus 18 E7 protein functionality.
    Liu S; Tian Y; Greenaway FT; Sun MZ
    Biochimie; 2010 Jul; 92(7):901-8. PubMed ID: 20211680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus type 16 E6 proteins with glycine substitution for cysteine in the metal-binding motif.
    Kanda T; Watanabe S; Zanma S; Sato H; Furuno A; Yoshiike K
    Virology; 1991 Dec; 185(2):536-43. PubMed ID: 1660194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scanning the structure and antigenicity of HPV-16 E6 and E7 oncoproteins using antipeptide antibodies.
    Stacey SN; Eklund C; Jordan D; Smith NK; Stern PL; Dillner J; Arrand JR
    Oncogene; 1994 Feb; 9(2):635-45. PubMed ID: 7507231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
    Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
    J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The secondary structure of the von Willebrand factor type A domain in factor B of human complement by Fourier transform infrared spectroscopy. Its occurrence in collagen types VI, VII, XII and XIV, the integrins and other proteins by averaged structure predictions.
    Perkins SJ; Smith KF; Williams SC; Haris PI; Chapman D; Sim RB
    J Mol Biol; 1994 Apr; 238(1):104-19. PubMed ID: 8145250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The carboxyl-terminal zinc-binding domain of the human papillomavirus E7 protein can be functionally replaced by the homologous sequences of the E6 protein.
    Mavromatis KO; Jones DL; Mukherjee R; Yee C; Grace M; Münger K
    Virus Res; 1997 Nov; 52(1):109-18. PubMed ID: 9453149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity.
    Massimi P; Pim D; Banks L
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2607-13. PubMed ID: 9349482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes.
    Jewers RJ; Hildebrandt P; Ludlow JW; Kell B; McCance DJ
    J Virol; 1992 Mar; 66(3):1329-35. PubMed ID: 1310752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubulin secondary structure analysis, limited proteolysis sites, and homology to FtsZ.
    de Pereda JM; Leynadier D; Evangelio JA; Chacón P; Andreu JM
    Biochemistry; 1996 Nov; 35(45):14203-15. PubMed ID: 8916905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7.
    Ohlenschläger O; Seiboth T; Zengerling H; Briese L; Marchanka A; Ramachandran R; Baum M; Korbas M; Meyer-Klaucke W; Dürst M; Görlach M
    Oncogene; 2006 Sep; 25(44):5953-9. PubMed ID: 16636661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and biophysical characterization of a minimal functional domain and of an N-terminal Zn2+-binding fragment from the human papillomavirus type 16 E6 protein.
    Lipari F; McGibbon GA; Wardrop E; Cordingley MG
    Biochemistry; 2001 Feb; 40(5):1196-204. PubMed ID: 11170444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein.
    Beerheide W; Bernard HU; Tan YJ; Ganesan A; Rice WG; Ting AE
    J Natl Cancer Inst; 1999 Jul; 91(14):1211-20. PubMed ID: 10413422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific recognition of four-way DNA junctions by the C-terminal zinc-binding domain of HPV oncoprotein E6.
    Ristriani T; Nominé Y; Masson M; Weiss E; Travé G
    J Mol Biol; 2001 Jan; 305(4):729-39. PubMed ID: 11162088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of the HPV E7 proteins with the pCAF acetyltransferase.
    Avvakumov N; Torchia J; Mymryk JS
    Oncogene; 2003 Jun; 22(25):3833-41. PubMed ID: 12813456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of the gamma human papillomavirus type 197 E6 and E7 associated cellular proteins.
    Grace M; Munger K
    Virology; 2017 Jan; 500():71-81. PubMed ID: 27771561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleic acid binding by zinc finger-like motif of human papillomavirus type 16 E7 oncoprotein.
    Chinami M; Inoue M; Masunaga K; Fukuma T; Shingu M; Toyoda T
    J Virol Methods; 1996 May; 59(1-2):173-6. PubMed ID: 8793845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-induced alpha-helix capping in conserved linker sequences is a determinant of binding affinity in Cys(2)-His(2) zinc fingers.
    Laity JH; Dyson HJ; Wright PE
    J Mol Biol; 2000 Jan; 295(4):719-27. PubMed ID: 10656784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
    Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
    Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.